Headlands Technologies’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Headlands Technologies's ADPT Position: Q3 2026 in Review
Headlands Technologies sold out of Adaptive Biotechnologies (ADPT) in Q3 2026, closing a stake of 9,718 shares — an estimated $208K sold.
Headlands Technologies first reported a position in ADPT in Q2 2023 and held it in 5 quarters. The position peaked at $896K in Q4 2025. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Headlands Technologies reported no remaining Adaptive Biotechnologies position as of Q3 2026 after selling out during the quarter.
- Headlands Technologies sold 9,718 Adaptive Biotechnologies shares in Q3 2026, an estimated $208K.
- Headlands Technologies first reported a position in Adaptive Biotechnologies in Q2 2023 and held it in 5 quarters.
- Headlands Technologies's Adaptive Biotechnologies position peaked at $896K in Q4 2025.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Headlands Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.